Amphastar的首席财务官和执行副总裁将在12月3日的投资者大会上讨论公司战略和研发管道。 Amphastar’s CFO and EVP to discuss company strategy and pipeline at Dec. 3 investor conference.

Amphartar制药公司(AMPH)宣布,CFO Bill Peters和EVP Tony Marrs将于2025年12月3日下午2:00 ET参加第37届Piper Sandler健康护理年会, Amphastar Pharmaceuticals (AMPH) announced that CFO Bill Peters and EVP Tony Marrs will join a fireside chat at the 37th Annual Piper Sandler Healthcare Conference on December 3, 2025, at 2:00 pm ET. 这项活动将在Amphastar的投资者关系网站上直播30天。 The event will be livestreamed and available on Amphastar’s investor relations website for 30 days. 该公司主要为医院和紧急护理开发和销售复杂的注射、吸入和内产产品,将讨论其商业战略、产品管道、监管进展和增长前景。 The company, which develops and markets complex injectable, inhalation, and intranasal products primarily for hospitals and urgent care, will discuss its business strategy, product pipeline, regulatory progress, and growth outlook. 关于财务业绩、产品开发和市场扩张的前瞻性报表受到证交会申报中详述的风险。 Forward-looking statements on financial performance, product development, and market expansion are subject to risks detailed in SEC filings.